Gynecologic Cancers | Clinical

New Metastatic Cervical Cancer Treatments Give Hope

January 21, 2021

Investigators treating patients with gynecologic malignancies are optimistic that multiple clinical trials exploring new second-line cervical cancer treatments will result in a much-anticipated breakthrough for the field.

Expert Highlights Latest Advances, Ongoing Trials During Cervical Cancer Awareness Month

January 08, 2021

Noelle G. Cloven, MD, discussed the current cervical cancer treatment paradigm, the unmet needs that still remain to be addressed, and encouraging new directions of research in clinical trials in honor of Cervical Cancer Awareness Month.

Novel HPV Vaccine Shows Reduced High-Grade Squamous Intraepithelial Lesions in Women

January 06, 2021

VGX-3100, a therapeutic DNA vaccine, achieved a 25% reduction or more reduction in HPV-16/18-associated vulvar high-grade squamous intraepithelial lesion in 63% of patients at 6 months after treatment with the agent, according to findings from an open-label phase 2 clinical trial.